Protection against brain injury after ischemic stroke by intravenous human amnion epithelial cells in combination with tissue plasminogen activator

BACKGROUND: Thrombolytic agents such as tissue plasminogen activator (tPA) are the only drug class approved to treat ischemic stroke and are usually administered within 4.5 h. However, only ~20% of ischemic stroke patients are eligible to receive the therapy. We previously demonstrated that early in...

Descripción completa

Detalles Bibliográficos
Autores principales: Barreto-Arce, Liz J., Kim, Hyun Ah, Chan, Siow Teng, Lim, Rebecca, Drummond, Grant R., Ma, Henry, Phan, Thanh G., Sobey, Christopher G., Zhang, Shenpeng R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311557/
https://www.ncbi.nlm.nih.gov/pubmed/37397458
http://dx.doi.org/10.3389/fnins.2023.1157236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311557/
https://www.ncbi.nlm.nih.gov/pubmed/37397458
http://dx.doi.org/10.3389/fnins.2023.1157236

Ejemplares similares